School of Psychology (A18), University of Sydney, Sydney, NSW 2006, Australia.
Psychopharmacology (Berl). 2010 Feb;208(3):433-41. doi: 10.1007/s00213-009-1743-9. Epub 2009 Dec 9.
In double-blind randomized placebo-controlled trials (RCT) of therapeutic interventions, the effects of the treatment may provide feedback that undermines blinding and consequently distorts measures of the effectiveness of the intervention.
This possibility was confirmed in an experimental model using a dummy placebo procedure whereby participants were led to believe that they were taking part in testing a cognitive-enhancing drug. In two experiments, false feedback given about cognitive performance influenced participants' beliefs about whether they had been allocated to the active treatment or placebo. These beliefs also appeared to influence actual cognitive performance in that participants who believed they had taken the active treatment had higher accuracy in Experiment 1 and faster reaction times in Experiment 2 than those who believed they had been given a placebo. The addition of no treatment control groups in Experiment 2 showed that these effects could not be accounted for by the feedback manipulation itself, thereby supporting expectancy as a causal factor.
These results indicate the importance of assessing participants' beliefs about their treatment allocation in real double-blind RCTs and considering if and how these may have affected the trial's outcome.
在治疗干预的双盲随机安慰剂对照试验(RCT)中,治疗效果可能会提供反馈,从而破坏盲法并扭曲干预效果的衡量。
通过使用模拟安慰剂程序的实验模型证实了这种可能性,参与者被引导相信他们正在测试一种认知增强药物。在两项实验中,关于认知表现的错误反馈影响了参与者对自己是否被分配到活性治疗或安慰剂的信念。这些信念似乎也影响了实际的认知表现,因为那些相信自己接受了活性治疗的参与者在实验 1 中的准确性更高,在实验 2 中的反应时间更快,而那些认为自己接受了安慰剂的参与者则更低。在实验 2 中增加无治疗对照组表明,这些影响不能仅用反馈操纵本身来解释,从而支持期望是一个因果因素。
这些结果表明,在真正的双盲 RCT 中评估参与者对其治疗分配的信念的重要性,并考虑这些信念是否以及如何影响试验结果。